ArticleOncotarget2017

Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling.

Jin-Wen Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.